John M. Schreiber

John M. Schreiber is the medical director of EEG and the Epilepsy Monitoring Unit and the director of Epilepsy Genetics at Children’s National Hospital. After earning his medical degree at the University of Maryland School of Medicine, he completed Pediatrics and Child Neurology training at Children’s National Hospital. Before returning in 2013, he served as an Epilepsy and Clinical Neurophysiology Fellow at the National Institutes of Health, gaining experience in epilepsy clinical trials and in neurogenetic disorders. His primary clinical and research interests are on the diagnosis, evaluation, and treatment of genetically-mediated epilepsies, particularly channelopathies.

Dr. Schreiber is the Principal Investigator at Children’s National for various epilepsy observational and interventional clinical trials with a focus on neurogenetic disorders. As the lead of PERC’s Genetics SIG, he has helped establish and grow PERC’s Genetic Epilepsy Database, with eleven centers approved and growing. In addition to his role on the PERC board, he is the co-chair for the Investigators’ Workshop Committee of the American Epilepsy Society and serves on several advisory boards, including the Epilepsy Foundation.